Pre Test Quiz: First line treatment
Which first line therapy has the highest reported overall
response rate and the longest median progression free
survival?
A. Ipilimumab + Nivolumab
B. Cabozantinib + Nivolumab
C. Lenvatinib + Pembrolizumab
D. Axitinib + Pembrolizumab